Author

Hanwen Zhang

Emory UniversityORCID 0000-0001-8955-7494Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hanwen Zhang5 papers · East China University of Science and Technology

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Chikun WangiD· 1 shared Edmund K. WalleriD· 1 shared Fanyuan ZengiD· 1 shared Gregory B. LesinskiiD· 1 shared Huanyu YaniD· 1 shared Jian-Ming LiiD· 1 shared Min Su· 1 shared Po-Chih HsuiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperDevelopmental Biology

Chikun WangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Developmental BiologyScience China Life SciencesPeer-reviewedNov 13, 2025

Plat safeguards maternally aged oocytes against programmed cell death through activating the Erk1/2 pathway

Xianying He, Hanwen Zhang, Ya Wang…·Xi Wang

This study identifies Plat's role in protecting aged oocytes from programmed cell death by activating the Erk1/2 pathway, showing tPA supplementation improves oocyte quality.

3 citations

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedMay 29, 2024

VPAC2 receptor signaling promotes pancreatic cancer cell growth and decreases the immunogenicity of the tumor microenvironment.

Tenzin Passang, Shuhua Wang, Hanwen Zhang…·Edmund K. Waller

This study shows that VPAC2 receptor signaling in pancreatic cancer cells promotes tumor growth and reduces immunogenicity, suggesting it as a therapeutic target.

17 citations

𝕏 PostBluesky